Nalaganje...
Trial of ganglioside GM1 in acute stroke.
Ganglioside GM1 (100 mg) was given daily by intramuscular injection for 28 days in a double-blind placebo controlled trial of acute stroke. No significant difference was detected in a 6 month follow-up period between well matched control and active groups. Although the number of patients studied was...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
1988
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1033029/ https://ncbi.nlm.nih.gov/pubmed/3066849 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|